(Adnkronos) - “L'insufficienza cardiaca in Italia colpisce circa 600.000 persone e l’incidenza aumenta con l’avanzare dell’età, nella popolazione over 65 anni arriva infatti a toccare il 10% di prevalenza”. A dirlo è stato Fabrizio Oliva, presidente dell’Associazione nazionale medici cardiologi ospedalieri (Anmco) e direttore di Cardiologia 1 presso l’ospedale Niguarda di Milano, in occasione della conferenza stampa con la quale è stato annunciato che l’Agenzia italiana del farmaco (Aifa) ha dato il via libera alla rimborsabilità di vericiguat, il nuovo farmaco per il trattamento dell’insufficienza cardiaca sintomatica cronica sviluppato da Bayer.
Category
🗞
NewsTranscript
00:00 (upbeat music)
00:02 (speaking in foreign language)
00:08 (speaking in foreign language)
00:12 (speaking in foreign language)
00:16 (speaking in foreign language)
00:20 (speaking in foreign language)
00:24 (speaking in foreign language)
00:28 (speaking in foreign language)
00:32 (speaking in foreign language)
00:36 (speaking in foreign language)
00:40 (speaking in foreign language)
00:44 (speaking in foreign language)
00:48 (speaking in foreign language)
00:52 (speaking in foreign language)
00:56 (speaking in foreign language)
01:00 (speaking in foreign language)
01:03 (speaking in foreign language)
01:07 (speaking in foreign language)
01:11 (speaking in foreign language)
01:15 (speaking in foreign language)
01:19 (speaking in foreign language)
01:23 (speaking in foreign language)
01:27 (speaking in foreign language)
01:31 (speaking in foreign language)
01:35 (speaking in foreign language)
01:39 (speaking in foreign language)
01:43 (speaking in foreign language)
01:47 (speaking in foreign language)
01:50 (speaking in foreign language)
01:54 in the process of recovery before resigning.